Asymchem Laboratories (Tianjin) Co., Ltd. (002821.SZ)
CNY 78.25
(0.2%)
CNY 78.25
(0.2%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 3.74 Billion | 3.28 Billion | 113.15 Million | 569.29 Million | 600.86 Million | 415.06 Million |
| Net Income | 2.26 Billion | 3.29 Billion | 1.06 Billion | 722.05 Million | 553.86 Million | 406.45 Million |
| Depreciation & Amortization | 486.86 Million | 341.73 Million | 214.32 Million | 156.82 Million | 122.22 Million | 103.48 Million |
| Deferred income taxes | -7.26 Million | -18.28 Million | -51.05 Million | -12.74 Million | -304.16 Thousand | -6.95 Million |
| Stock-based compensation | 54.59 Million | 40.98 Million | 51.05 Million | 17.95 Million | 15.18 Million | 15.94 Million |
| Change in working capital | 992.51 Million | -71.25 Million | -1.2 Billion | -381.59 Million | -110.06 Million | -120.48 Million |
| Other non-cash items | 25.49 Million | -312.78 Million | 35.26 Million | 66.79 Million | 19.95 Million | 25.61 Million |
| Investing Cash Flow | -2.89 Billion | -4.67 Billion | -2.2 Billion | -1.1 Billion | -699.89 Million | -583.7 Million |
| Investments in PPE | -1.24 Billion | -2.15 Billion | -1.65 Billion | -1.01 Billion | -510.75 Million | -543.15 Million |
| Acquisitions | 98.86 Million | -30 Million | -102.52 Million | -8.72 Million | 117.21 Thousand | - |
| Investment purchases | -29.27 Billion | -9.95 Billion | -4.37 Billion | -73.86 Million | -572 Million | -37.56 Million |
| Sales/Maturities of investments | 27.52 Billion | 7.4 Billion | 3.93 Billion | 22 Thousand | 393.52 Million | 9.68 Million |
| Other Investing Activities | 3.71 Million | 58.85 Million | 3.05 Million | -4.25 Million | -10.78 Million | -12.65 Million |
| Financing Cash Flow | -542.02 Million | -742.52 Million | 6.21 Billion | 2.26 Billion | -102.09 Million | -42.7 Million |
| Debt repayment | -2.91 Million | -374.57 Million | -692.68 Million | -140 Million | -30 Million | - |
| Dividends payments | -663.89 Million | -211.27 Million | -145.56 Million | -115.63 Million | -92.52 Million | -80.53 Million |
| Common Stock Repurchased | -9.31 Million | -814.58 Million | -6.56 Million | -2.79 Million | -7.09 Million | -279 Thousand |
| Common Stock Issuance | - | 814.58 Million | 6.01 Billion | -3.58 Million | 7.09 Million | 33.04 Million |
| Other Financing Activities | 118.95 Million | -149.14 Million | 1.04 Billion | 2.53 Billion | 21.02 Million | 37.83 Million |
| Accounts receivables | 500.82 Million | -586.12 Million | -853.01 Million | -421.82 Million | -161.88 Million | -79.4 Million |
| Accounts payables | -99.01 Million | 647.44 Million | 173.25 Million | 323.54 Million | 76.79 Million | 99.12 Million |
| Inventory | 554.25 Million | -114.29 Million | -669.73 Million | -270.56 Million | -24.66 Million | -163.89 Million |
| Other working capital | 36.44 Million | -18.28 Million | 143.79 Million | -12.74 Million | -304.16 Thousand | 43.4 Million |
| Cash at beginning of period | 4.43 Billion | 6.23 Billion | 2.12 Billion | 414.38 Million | 604.52 Million | 827.79 Million |
| Cash at end of period | 7.1 Billion | 4.41 Billion | 6.23 Billion | 2.12 Billion | 414.38 Million | 604.52 Million |
| Capital Expenditure | -1.24 Billion | -2.15 Billion | -1.65 Billion | -1.01 Billion | -510.75 Million | -543.15 Million |
| Effect of forex changes on cash | 36.96 Million | 313.17 Million | -8.17 Million | -28.21 Million | 10.98 Million | -11.91 Million |
| Net cash flow / Change in cash | 2.67 Billion | -1.81 Billion | 4.11 Billion | 1.7 Billion | -190.14 Million | -223.26 Million |
| Free Cash Flow | 2.5 Billion | 1.13 Billion | -1.54 Billion | -445.66 Million | 90.11 Million | -128.09 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 211.19 Million | 217.16 Million | 281.97 Million | 58.7 Million | 2.26 Billion | 523.73 Million |
| Depreciation & Amortization | - | 127.16 Million | 127.16 Million | 123.54 Million | 486.86 Million | 137.64 Million |
| Deferred income taxes | - | - | - | -492.64 Million | -7.26 Million | -107.69 Million |
| Stock-based compensation | - | 33.96 Million | 16.98 Million | 31.61 Million | 54.59 Million | 364.00 |
| Change in working capital | - | 432.46 Million | - | 461.03 Million | 992.51 Million | -69.21 Million |
| Other non-cash items | -50.9 Million | 340.96 Million | 242.07 Million | 73.31 Million | 25.49 Million | 126.59 Million |
| Investing Cash Flow | -371.34 Million | -464.23 Million | -317.98 Million | -1.85 Billion | -2.89 Billion | -199.15 Million |
| Investments in PPE | -240.39 Million | -334.28 Million | -319.38 Million | -416.77 Million | -1.24 Billion | -294.39 Million |
| Acquisitions | 273 Million | -236.3 Million | - | 17.39 Million | 98.86 Million | 9.99 Million |
| Investment purchases | 6.33 Billion | -3.24 Billion | -3.32 Billion | -29.22 Billion | -29.27 Billion | 18.64 Billion |
| Sales/Maturities of investments | -6.69 Billion | 3.35 Billion | 3.33 Billion | 27.58 Billion | 27.52 Billion | -18.31 Billion |
| Other Investing Activities | -41.83 Million | -2809.15 | -14.35 Million | 180.08 Million | 3.71 Million | -240.78 Million |
| Financing Cash Flow | -484.49 Million | -1.19 Billion | -218.69 Million | -27.09 Million | -542.02 Million | -44.63 Million |
| Debt repayment | - | - | - | -2.91 Million | -2.91 Million | -209.00 |
| Dividends payments | - | -383.64 Million | - | -663.89 Million | -663.89 Million | -44.63 Million |
| Common Stock Repurchased | 1.01 Billion | -1.01 Billion | - | -9.31 Million | -9.31 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.49 Billion | -164.95 Million | -218.69 Million | 633.88 Million | 118.95 Million | 209.00 |
| Accounts receivables | - | 470.32 Million | - | 544.51 Million | 500.82 Million | 23.11 Million |
| Accounts payables | - | - | - | - | -99.01 Million | -30.24 Million |
| Inventory | - | -62.37 Million | - | -75.79 Million | 554.25 Million | -92.33 Million |
| Other working capital | - | 24.5 Million | - | -7.69 Million | 36.44 Million | 30.24 Million |
| Cash at beginning of period | 5.67 Billion | 7.54 Billion | 7.1 Billion | 7.09 Billion | 4.43 Billion | 5.55 Billion |
| Cash at end of period | 5.2 Billion | 5.67 Billion | 7.54 Billion | 7.1 Billion | 7.1 Billion | 5.9 Billion |
| Capital Expenditure | -240.39 Million | -334.28 Million | -319.38 Million | -416.77 Million | -1.24 Billion | -294.39 Million |
| Effect of forex changes on cash | - | 43.55 Million | 15.68 Million | 3.7 Million | 36.96 Million | -13.69 Million |
| Net cash flow / Change in cash | -476.8 Million | -1.86 Billion | 437.88 Million | 10.43 Million | 2.67 Billion | 353.57 Million |
| Free Cash Flow | -80.1 Million | 96.67 Million | 204.66 Million | 331.43 Million | 2.5 Billion | 316.67 Million |
GATEWAY
YONXF
HOEGF
AROC
064550
EVGIF